Healthdirect Australia is not responsible for the content and advertising on the external website you are now entering.
Simponi TM
Listen to the Pronunciation:
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: golimumab
Brand name
(ARTG)
: SIMPONI golimumab (rmc) 50 mg solution for injection pre-filled syringeConsumer Medicine Information (CMI)
Read the CMI leaflet for facts you need to know before, during and after taking your medicine.
Listen to the audio transcription of the CMI leaflet.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
(ARTG)
SIMPONI,Rheumatoid arthritis (RA),SIMPONI, in combination with methotrexate, is indicated for:,The treatment of moderate to severely active rheumatoid arthritis in adult patients when the response to disease-modifying anti-rheumatic drug therapy, including methotrexate, has been inadequate. SIMPONI has also been shown to inhibit the progression of joint damage as measured by X-ray.,Psoriatic arthritis (PsA),SIMPONI, alone or in combination with methotrexate, is indicated for:,The treatment of active and progressive psoriatic arthritis in adult patients when the response to previous disease-modifying anti-rheumatic drug therapy has been inadequate. SIMPONI has also been shown to inhibit the progression of peripheral joint damage as measured by X-ray in patients with polyarticular symmetrical subtypes of the disease, and improve physical function.,Axial Spondyloarthritis,Ankylosing spondylitis (AS),SIMPONI is indicated for:,The treatment of active ankylosing spondylitis in adult patients. Non-radiographic axial spondyloarthritis (nr-Axial SpA),SIMPONI is indicated for the treatment of adults with active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or magnetic resonance imaging (MRI) evidence, who have had an inadequate response to, or are intolerant to, nonsteroidal anti-inflammatory drugs (NSAIDs).,Ulcerative colitis (UC),SIMPONI is indicated for: The treatment of moderately to severely active ulcerative colitis in adult patients who have had an inadequate response to conventional therapy. Patients should show a clinical response within 6 weeks of treatment to continue treatment beyond that time (see section 5.1 PHARMACODYNAMIC PROPERTIES, Clinical Trials).
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, solution
- Subcutaneous
- Clear to slightly opalescent, colourless to light yellow solution.
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Refrigerate
- Shelf lifetime is 3 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 1 syringe (0.5 mL) pack
- 3 syringes (0.5 mL) pack
Is this medicine subsidised ?
(PBS)
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on May, 1 2025. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient golimumab
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Need more information?
These trusted information partners have more on this topic.
Top results
Medication for IBD – Crohn’s & Colitis Australia (CCA)
For more than 30 years, Crohn’s & Colitis Australia has been empowering the more than 100,000 Australian's living with Crohn’s disease or IBD.
Read more on Crohn's & Colitis Australia website
Ulcerative colitis - myDr.com.au
Ulcerative colitis is one of 2 major types of inflammatory bowel disease — a condition which causes the bowel (colon) to become inflamed. It affects people of all ages, but usually starts between 15 and 30 years.
Read more on MyDoctor website
Covid and Crohn’s & Colitis – Crohn’s & Colitis Australia (CCA)
For more than 30 years, Crohn’s & Colitis Australia has been empowering the more than 100,000 Australian's living with Crohn’s disease or IBD.
Read more on Crohn's & Colitis Australia website
Top results
